title: Loss of heterozygosity of 17p13, with possible involvement of ACADVL and ALOX15B, in the pathogenesis of adrenocortical tumors.
abstract: OBJECTIVE
  To determine the minimal common region of loss on 17p13 in a cohort of adrenocortical carcinomas (ACCs) (defined by a Weiss score > or =3) and adrenocortical adenomas (ACAs) (defined by a Weiss score <3) and subsequently to assess 3 genes in this region that could be involved in adrenocortical tumorigenesis.
  
  
  BACKGROUND
  Loss of heterozygosity (LOH) of 17p13 has been demonstrated to occur more frequently in ACCs compared with ACAs.
  
  
  METHODS
  Using 12 microsatellite markers across 17p13, LOH analysis was performed on 37 paired blood and adrenocortical tumor samples (23 ACC and 14 ACA samples) to determine the minimal common region of loss for ACCs and ACAs. From this minimal region of loss, 3 genes were selected for quantitative real time reverse transcription polymerase chain reaction analysis on 20 ACCs and 30 ACAs.
  
  
  RESULTS
  LOH at 17p13 was found in 74% of ACCs compared with 14% of ACAs. There was a 10.4-Mb common minimal region of loss in ACCs whereas no minimal region of loss in ACAs could be demonstrated. Expression of Acyl coenzyme-A dehydrogenase very long chain (ACADVL) and Arachidonate 15-lipoxygenase second type (ALOX15B) was significantly down-regulated in ACCs compared with ACAs whereas there was no difference in expression of Potassium channel tetramerization domain containing 11 (KCTD11) in ACCs and ACAs.
  
  
  CONCLUSIONS
  We demonstrated a minimal common region of loss of 10.4-Mb on 17p13 in ACCs and within this region, we found that ACADVL and ALOX15B expression are good discriminators between ACCs and ACAs.
authors.affiliation: Cancer Genetics, Kolling Institute of Medical Research, Royal North Shore Hospital, New South Wales, Australia.
authors.forename: Patsy S H
authors.initials: PS
authors.lastname: Soon
authors.forename: Rossella
authors.initials: R
authors.lastname: Libe
authors.forename: Diana E
authors.initials: DE
authors.lastname: Benn
authors.forename: Anthony
authors.initials: A
authors.lastname: Gill
authors.forename: Janet
authors.initials: J
authors.lastname: Shaw
authors.forename: Mark S
authors.initials: MS
authors.lastname: Sywak
authors.forename: Lionel
authors.initials: L
authors.lastname: Groussin
authors.forename: Xavier
authors.initials: X
authors.lastname: Bertagna
authors.forename: Christine
authors.initials: C
authors.lastname: Gicquel
authors.forename: Jerome
authors.initials: J
authors.lastname: Bertherat
authors.forename: Kerrie L
authors.initials: KL
authors.lastname: McDonald
authors.forename: Stan B
authors.initials: SB
authors.lastname: Sidhu
authors.forename: Bruce G
authors.initials: BG
authors.lastname: Robinson
mesh_terms: D044944:Acyl-CoA Dehydrogenases / Q000235:genetics*; D000306:Adrenal Cortex Neoplasms / Q000201:enzymology / Q000235:genetics*; D000368:Aged; D001092:Arachidonate 12-Lipoxygenase / Q000235:genetics*; D002886:Chromosomes, Human, Pair 17; D005260:Female; D015972:Gene Expression Regulation, Neoplastic; D016147:Genes, Tumor Suppressor; D005819:Genetic Markers; D006801:Humans; D019656:Loss of Heterozygosity; D008297:Male; D018895:Microsatellite Repeats; D008875:Middle Aged; D020133:Reverse Transcriptase Polymerase Chain Reaction; D018709:Statistics, Nonparametric
chemical_list: D005819:Genetic Markers; D001092:Arachidonate 12-Lipoxygenase; D044944:Acyl-CoA Dehydrogenases